Conclusion
Based on our results, we conclude that ECMO placement can improve refractory cases of ARDS due to COVID-19. More research is needed to better understand the true efficacy of ECMO in treating COVID-19 and the mortality rate associated with it.
Table 1 : Contraindications for ECMO in COVID 19.